Medical Procedure News

RSS

Majority of women do not receive guideline-recommended breast cancer adjuvant therapy

A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute.

7 Dec 2011

Diabetes increases risk of emergency caesarean birth in women with poorly contracting uterus

Researchers at the University of Liverpool have found that the strength of uterine contractions in diabetic pregnant women is significantly weaker than in non-diabetic women, increasing the risk of emergency caesarean birth.

7 Dec 2011

Study compares two radiation therapy techniques available to women with breast cancer

Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from The University of Texas MD Anderson Cancer Center.

7 Dec 2011

UCSF resident to receive 2012 William P. Van Wagenen Fellowship

The William P. Van Wagenen Fellowship Selection Committee has announced Matthew Christopher Tate, MD, as the recipient of the 2012 William P. Van Wagenen Fellowship. Dr. Tate, a resident in neurological surgery at University of California in San Francisco, will commence the fellowship on July 1, 2012.

7 Dec 2011

Breast reconstruction surgery to become safer and more realistic

Breast reconstruction surgery will become both safer and more realistic thanks to research led by Queensland University of Technology (QUT) in Brisbane, Australia.

7 Dec 2011

Breast reconstruction after mastectomy safe for older women

Breast cancer is on the rise and 48 percent of all breast cancers occur in women older than 65, but very few of them choose to have breast reconstruction. A new study from Wake Forest Baptist Medical Center sought to determine if breast reconstruction after mastectomy is safe for older women. The answer is yes.

7 Dec 2011

Donated permanent pacemakers safe and effective for Indian heart patients

Many heart patients in India are too poor to afford pacemakers. But a study has found that removing pacemakers from deceased Americans, resterilizing the devices and implanting them in Indian patients "is very safe and effective."

From Medtronic 7 Dec 2011

TAU develops tumor destruction method that also creates immunity

Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.

7 Dec 2011

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women's Cancer Center.

7 Dec 2011

Mayo Clinic in Florida now offers kidney and pancreas transplants for HIV-positive patients

Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in terms of patient and allograft survival as non-HIV positive organ transplant recipients, says Mary Prendergast, M.D., a kidney specialist whose focus is the care of patients who receive kidney and pancreas transplants.

7 Dec 2011

Therakos commences enrollment in photopheresis Phase IIb clinical study for chronic GvHD

Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).

6 Dec 2011

Xeltis receives PEI conditional approval to initiate tissue-engineered cardiovascular graft study

Xeltis, a biomedical technology company developing growing, living and self-healing cardiovascular implants using tissue-engineering technology, has announced conditional approval by the Paul Erlich Institute (PEI) in Germany to commence the first clinical study of its tissue-engineered cardiovascular grafts.

6 Dec 2011

GE Healthcare, UCSF collaborate for cord blood project

UCSF and the Cell Technologies business of GE Healthcare Life Sciences have begun a unique collaboration aimed at overcoming the lack of blood-forming stem cells available to patients suffering from life-threatening diseases such as lymphoma, myeloma, leukemia or sickle cell anemia.

6 Dec 2011

Breast cancer patients might experience prolonged fatigue years after chemotherapy

In a follow-up study, researchers at Moffitt Cancer Center and colleagues have found that patients who receive chemotherapy for breast cancer might experience prolonged fatigue years after their therapy.

6 Dec 2011

MHI cardiologists use ABSORB bioresorbable vascular scaffold to treat CAD

The interventional cardiology team at the Montreal Heart Institute (MHI) used the world's first drug eluting bioresorbable vascular scaffold to successfully treat a woman suffering from coronary artery disease. This landmark procedure was performed by Dr. Jean-Fran-ois Tanguay, interventional cardiologist and coordinator of the Coronary Unit, as part of the ABSORB EXTEND clinical trial.

6 Dec 2011

Medicare tightening payments for 'big ticket' cardiology and orthopedic procedures in 11 states

In an effort to rein in costs, the Centers for Medicare and Medicaid Services will in 2012 perform an audit before paying for certain cardiology and orthopedic procedures in key states, including Florida.

6 Dec 2011

Aspirin decreases risk of major complications from cardiac surgery

Aspirin taken within five days of cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, a lengthy intensive care unit stay and even early death (30-day mortality), according to a study by researchers at Thomas Jefferson University and UC Davis Medical Center set to appear in the journal Annals of Surgery.

6 Dec 2011

Medical Procedure News

Majority of women do not receive guideline-recommended breast cancer adjuvant therapy

Diabetes increases risk of emergency caesarean birth in women with poorly contracting uterus

Study compares two radiation therapy techniques available to women with breast cancer

UCSF resident to receive 2012 William P. Van Wagenen Fellowship

Breast reconstruction surgery to become safer and more realistic

Breast reconstruction after mastectomy safe for older women

Donated permanent pacemakers safe and effective for Indian heart patients

TAU develops tumor destruction method that also creates immunity

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

Mayo Clinic in Florida now offers kidney and pancreas transplants for HIV-positive patients

Therakos commences enrollment in photopheresis Phase IIb clinical study for chronic GvHD

Xeltis receives PEI conditional approval to initiate tissue-engineered cardiovascular graft study

GE Healthcare, UCSF collaborate for cord blood project

Breast cancer patients might experience prolonged fatigue years after chemotherapy

MHI cardiologists use ABSORB bioresorbable vascular scaffold to treat CAD

Medicare tightening payments for 'big ticket' cardiology and orthopedic procedures in 11 states

Aspirin decreases risk of major complications from cardiac surgery

Acupuncture for chemotherapy-induced peripheral neuropathy

Enrollment commences in Estech's HISTORIC-AF staged hybrid ablation study

Herzig Eye Institute named TearScience's first Center of Excellence

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News